Suven Life Sciences Ltd's net profit increased 9.8 per cent at Rs 2.56 crore (Rs 2.33 crore) in the second quarter ended September 30, 2011.
The total revenue of the Hyderabad-based company grew by 31 pc at Rs 49.6 crore (Rs 37.8 crore). The earnings per share stood at Rs 0.22 (Rs 0.20).
During the quarter under review, Suven spent Rs 8.7 crore on research and development for drug discovery, according to a release.
The company's scrip ended at Rs 16.80 on the Bombay Stock Exchange on Tuesday. –